Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
1475 | 2637 | 48.8 | 90% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
518 | 3 | ANGIOGENESIS//RETINOPATHY OF PREMATURITY//ENDOSTATIN | 20826 |
361 | 2 | ANGIOGENESIS//ENDOSTATIN//VEGF | 17372 |
1475 | 1 | VEGF//FLT 1//VEGF RECEPTORS | 2637 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | VEGF | authKW | 281871 | 17% | 6% | 443 |
2 | FLT 1 | authKW | 277820 | 3% | 33% | 73 |
3 | VEGF RECEPTORS | authKW | 206856 | 3% | 25% | 71 |
4 | ANGIOGENESIS | authKW | 200131 | 25% | 3% | 668 |
5 | VEGFR 1 | authKW | 178600 | 2% | 31% | 50 |
6 | VASCULAR ENDOTHELIAL GROWTH FACTOR | authKW | 173850 | 12% | 5% | 328 |
7 | VEGFR2 | authKW | 162182 | 4% | 14% | 97 |
8 | PLACENTA GROWTH FACTOR | authKW | 126417 | 1% | 38% | 29 |
9 | VEGF B | authKW | 125800 | 1% | 45% | 24 |
10 | VEGF165B | authKW | 104194 | 0% | 75% | 12 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Oncology | 6473 | 27% | 0% | 706 |
2 | Cell Biology | 2586 | 18% | 0% | 462 |
3 | Biochemistry & Molecular Biology | 2208 | 27% | 0% | 712 |
4 | Medicine, Research & Experimental | 827 | 8% | 0% | 203 |
5 | Peripheral Vascular Diseases | 520 | 5% | 0% | 128 |
6 | Biophysics | 449 | 6% | 0% | 153 |
7 | Pathology | 410 | 4% | 0% | 111 |
8 | Hematology | 342 | 4% | 0% | 113 |
9 | Cardiac & Cardiovascular System | 140 | 4% | 0% | 111 |
10 | Biotechnology & Applied Microbiology | 97 | 4% | 0% | 109 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | ENDOTHELIAL CELL BIOL UNIT | 96165 | 1% | 46% | 18 |
2 | MICROVASC S | 89924 | 1% | 30% | 26 |
3 | GAKUBUNKAN PHYSIOL MED | 46307 | 0% | 67% | 6 |
4 | PRECLIN VET | 31277 | 0% | 27% | 10 |
5 | BIOMOL MOL CELL BIOL | 26048 | 0% | 75% | 3 |
6 | BIOMEDICUM HELSINKIMOL CANC BIOL PROGRAM | 23156 | 0% | 100% | 2 |
7 | MED NEUROL SURG SECT | 23156 | 0% | 100% | 2 |
8 | PHYSIOL PHARMACOL VET SCI | 20838 | 0% | 60% | 3 |
9 | MICROVASC SBRISTOL HEART | 17364 | 0% | 50% | 3 |
10 | TRANSGENE TECHNOL GENE THER Y | 17054 | 1% | 6% | 24 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | GROWTH FACTORS | 7015 | 1% | 3% | 22 |
2 | CANCER RESEARCH | 2482 | 4% | 0% | 94 |
3 | NATO ADVANCED SCIENCE INSTITUTES SERIES, SERIES A, LIFE SCIENCES | 2048 | 0% | 2% | 8 |
4 | JOURNAL OF BIOLOGICAL CHEMISTRY | 1415 | 6% | 0% | 146 |
5 | CANCER AND METASTASIS REVIEWS | 1347 | 0% | 1% | 12 |
6 | INTERNATIONAL JOURNAL OF ONCOLOGY | 1347 | 1% | 0% | 34 |
7 | BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS | 1135 | 3% | 0% | 86 |
8 | TRENDS IN CARDIOVASCULAR MEDICINE | 890 | 0% | 1% | 10 |
9 | MOLECULAR CANCER THERAPEUTICS | 699 | 1% | 0% | 16 |
10 | ONCOGENE | 682 | 1% | 0% | 34 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | VEGF | 281871 | 17% | 6% | 443 | Search VEGF | Search VEGF |
2 | FLT 1 | 277820 | 3% | 33% | 73 | Search FLT+1 | Search FLT+1 |
3 | VEGF RECEPTORS | 206856 | 3% | 25% | 71 | Search VEGF+RECEPTORS | Search VEGF+RECEPTORS |
4 | ANGIOGENESIS | 200131 | 25% | 3% | 668 | Search ANGIOGENESIS | Search ANGIOGENESIS |
5 | VEGFR 1 | 178600 | 2% | 31% | 50 | Search VEGFR+1 | Search VEGFR+1 |
6 | VASCULAR ENDOTHELIAL GROWTH FACTOR | 173850 | 12% | 5% | 328 | Search VASCULAR+ENDOTHELIAL+GROWTH+FACTOR | Search VASCULAR+ENDOTHELIAL+GROWTH+FACTOR |
7 | VEGFR2 | 162182 | 4% | 14% | 97 | Search VEGFR2 | Search VEGFR2 |
8 | PLACENTA GROWTH FACTOR | 126417 | 1% | 38% | 29 | Search PLACENTA+GROWTH+FACTOR | Search PLACENTA+GROWTH+FACTOR |
9 | VEGF B | 125800 | 1% | 45% | 24 | Search VEGF+B | Search VEGF+B |
10 | VEGF165B | 104194 | 0% | 75% | 12 | Search VEGF165B | Search VEGF165B |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | FERRARA, N , DAVISSMYTH, T , (1997) THE BIOLOGY OF VASCULAR ENDOTHELIAL GROWTH FACTOR.ENDOCRINE REVIEWS. VOL. 18. ISSUE 1. P. 4 -25 | 111 | 52% | 3006 |
2 | NEUFELD, G , COHEN, T , GENGRINOVITCH, S , POLTORAK, Z , (1999) VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF) AND ITS RECEPTORS.FASEB JOURNAL. VOL. 13. ISSUE 1. P. 9 -22 | 100 | 58% | 2380 |
3 | FERRARA, N , (2004) VASCULAR ENDOTHELIAL GROWTH FACTOR: BASIC SCIENCE AND CLINICAL PROGRESS.ENDOCRINE REVIEWS. VOL. 25. ISSUE 4. P. 581-611 | 144 | 36% | 1823 |
4 | FISCHER, C , MAZZONE, M , JONCKX, B , CARMELIET, P , (2008) FLT1 AND ITS LIGANDS VEGFB AND PLGF: DRUG TARGETS FOR ANTI-ANGIOGENIC THERAPY?.NATURE REVIEWS CANCER. VOL. 8. ISSUE 12. P. 942 -956 | 117 | 59% | 255 |
5 | ROBINSON, CJ , STRINGER, SE , (2001) THE SPLICE VARIANTS OF VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF) AND THEIR RECEPTORS.JOURNAL OF CELL SCIENCE. VOL. 114. ISSUE 5. P. 853 -865 | 120 | 63% | 561 |
6 | FERRARA, N , GERBER, HP , LECOUTER, J , (2003) THE BIOLOGY OF VEGF AND ITS RECEPTORS.NATURE MEDICINE. VOL. 9. ISSUE 6. P. 669-676 | 58 | 46% | 4713 |
7 | KOCH, S , TUGUES, S , LI, XJ , GUALANDI, L , CLAESSON-WELSH, L , (2011) SIGNAL TRANSDUCTION BY VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTORS.BIOCHEMICAL JOURNAL. VOL. 437. ISSUE . P. 169-183 | 111 | 43% | 285 |
8 | FERRARA, N , (1999) MOLECULAR AND BIOLOGICAL PROPERTIES OF VASCULAR ENDOTHELIAL GROWTH FACTOR.JOURNAL OF MOLECULAR MEDICINE-JMM. VOL. 77. ISSUE 7. P. 527 -543 | 111 | 53% | 826 |
9 | HICKLIN, DJ , ELLIS, LM , (2005) ROLE OF THE VASCULAR ENDOTHELIAL GROWTH FACTOR PATHWAY IN TUMOR GROWTH AND ANGIOGENESIS.JOURNAL OF CLINICAL ONCOLOGY. VOL. 23. ISSUE 5. P. 1011 -1027 | 90 | 41% | 1433 |
10 | CEBE-SUAREZ, S , ZEHNDER-FJALLMAN, A , BALLMER-HOFER, K , (2006) THE ROLE OF VEGF RECEPTORS IN ANGIOGENESIS; COMPLEX PARTNERSHIPS.CELLULAR AND MOLECULAR LIFE SCIENCES. VOL. 63. ISSUE 5. P. 601 -615 | 124 | 54% | 151 |
Classes with closest relation at Level 1 |